Ever Source Wealth Advisors, LLC Seagen Inc. Transaction History

Ever Source Wealth Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$191.51 - $216.16 $164,890 - $186,113	-861 Reduced 95.56%	40 $8,000
Q2 2023 Aug 04, 2023	SELL	$187.64 - $206.25 $81,998 - $90,131	-437 Reduced 32.66%	901 $173,000
Q1 2023 May 11, 2023	BUY	$127.59 - $203.08 $10,079 - $16,043	79 Added 6.27%	1,338 $270,000
Q4 2022 Feb 09, 2023	SELL	$117.37 - $139.17 $38,849 - $46,065	-331 Reduced 20.82%	1,259 $161,000
Q3 2022 Nov 07, 2022	SELL	$135.27 - $180.11 $65,470 - $87,173	-484 Reduced 23.34%	1,590 $218,000
Q2 2022 Aug 01, 2022	BUY	$108.81 - $179.33 $110,550 - $182,199	1,016 Added 96.03%	2,074 $367,000
Q1 2022 May 25, 2022	BUY	$119.61 - $157.85 $101,907 - $134,488	852 Added 413.59%	1,058 $152,000
Q4 2021 Feb 07, 2022	BUY	$142.57 - $190.86 $29,369 - $39,317	206 New	206 $32,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.